“Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-Rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients With Advanced Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s125. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1098.